Long-term Suppression of Recurrent Herpes Labialis by Low-Dose Oral Acyclovir in an Immunocompromised Patient

doi:10.1001/archinte.1986.00360190230035

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Vol. 146 No. 7, July 1986

Online Only
	•	Online First Table of Contents

CLINICAL OBSERVATIONS

•	Online Features

This Article
•	References
•	Full text PDF
•	Reply to article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Contact me when this article is cited

Related Content
•	Similar articles in this journal

Social Bookmarking
	What's this?

Long-term Suppression of Recurrent Herpes Labialis by Low-Dose Oral Acyclovir in an Immunocompromised Patient

Michael Dan, MD; Yardena Siegman-Igra, MD; Miriam Weinberg, MSc; Dan Michaeli, MD

Arch Intern Med. 1986;146(7):1438-1440.

Abstract

• A patient with chronic lymphocytic leukemia and severeand frequently recurring herpes labialis received oral acyclovirfor more than 18 months, during most of this period at a lowdosage (400 mg/d). This regimen was fully successful in preventingrecurrences, with no adverse effects.

(Arch Intern Med 1986;146:1438-1440)

Author Affiliations

From the Infectious Diseases Unit (Drs Dan, Siegman-Igra, and Michaeli) and Department of Microbiology (Mrs Weinberg), Ichilov Hospital, Tel Aviv (Israel) Medical Center; and Tel Aviv University Sackler School of Medicine (Drs Dan, Siegman-Igra, and Michaeli and Mrs Weinberg).

Footnotes

Accepted for publication Dec 12, 1985.

Reprint requests to Ichilov Hospital, 6 Weizmann St, 64239 TelAviv, Israel (Dr Dan).

Add to CiteULike CiteULike Add to Connotea Connotea Add to Delicious Delicious Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

| | |